From Drug Testing to Organ-on-a-Chip: High-Growth Applications Driving the 3D Bioprinting Market Forward.
The commercial viability of the 3D bioprinting market is currently anchored not just by the distant promise of organ transplantation, but by its immediate, high-value applications in pharmaceutical research and toxicology testing. The most significant trending application in this space is the creation of 'organ-on-a-chip' models and bioprinted tissue constructs for drug screening. These models...
0 Commentaires 0 Parts 28 Vue 0 Aperçu